Malmedy, Belgium

Stéphane Kohnen

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universitéde Liége. Active years: 2013.


 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Stéphane Kohnen: Innovator in Neutrophil Cell Activation Measurement

Introduction

Stéphane Kohnen is a notable inventor based in Malmedy, Belgium. He has made significant contributions to the field of biomedical research, particularly in the measurement of neutrophil cell activation. His work is essential for advancing diagnostic methods and understanding immune responses.

Latest Patents

Stéphane Kohnen holds a patent for a "Method and kit for the measurement of neutrophil cell activation." This invention focuses on accurate detection methods for measuring myeloperoxidase (MPO) levels in complex biological samples, specifically equine neutrophils. The patent also discusses the use of ELISA and SIEFED assays for detection, highlighting that the sensitivity of active peroxidase activity can be enhanced by the addition of nitrite. This measurement is crucial for various applications, including the prediction, diagnosis, and monitoring of pathologies related to neutrophil activation and destruction.

Career Highlights

Kohnen is affiliated with the Université de Liège, where he continues to engage in innovative research. His work has implications for evaluating drugs and immunomodulators, assessing immune responses, and studying the ability of cells to combat microorganisms.

Collaborations

Stéphane Kohnen collaborates with esteemed colleagues such as Didier Serteyn and Ginette Dupont, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Stéphane Kohnen's contributions to the field of neutrophil cell activation measurement exemplify the importance of innovation in biomedical research. His patent and ongoing work at the Université de Liège are paving the way for advancements in diagnostic methods and therapeutic evaluations.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…